INTRODUCTION: Tobacco use is associated with poor outcomes in cancer patients, but there is little information from oncology providers on their practice patterns or perceptions regarding tobacco use and smoking cessation in these patients. METHODS: An online survey of practices, perceptions, and barriers to tobacco assessment and cessation in cancer patients was conducted in members of the International Association for the Study of Lung Cancer (IASLC). Responses of physician-level respondents were analyzed and reported. RESULTS: Responses from 1507 IASLC members who completed the survey are reported as representing 40.5% of IASLC members. More than 90% of physician respondents believe current smoking affects outcome and that cessation should be a standard part of clinical care. At the initial patient visit, 90% ask patients about tobacco use, 79% ask patients whether they will quit, 81% advise patients to stop tobacco use, but only 40% discuss medication options, 39% actively provide cessation assistance, and fewer yet address tobacco at follow-up. Dominant barriers to physician cessation effort are pessimism regarding their ability to help patients stop using tobacco (58%) and concerns about patient resistance to treatment (67%). Only 33% report themselves to be adequately trained to provide cessation interventions. CONCLUSION: Physicians who care for lung cancer patients recognize the importance of tobacco cessation as a necessary part of clinical care, but many still do not provide assistance to their patients as a routine part of cancer care. Increasing tobacco cessation activities will require increased assessment and cessation at diagnosis and during follow-up, increased clinician education, and improved tobacco cessation methods.
INTRODUCTION:Tobacco use is associated with poor outcomes in cancerpatients, but there is little information from oncology providers on their practice patterns or perceptions regarding tobacco use and smoking cessation in these patients. METHODS: An online survey of practices, perceptions, and barriers to tobacco assessment and cessation in cancerpatients was conducted in members of the International Association for the Study of Lung Cancer (IASLC). Responses of physician-level respondents were analyzed and reported. RESULTS: Responses from 1507 IASLC members who completed the survey are reported as representing 40.5% of IASLC members. More than 90% of physician respondents believe current smoking affects outcome and that cessation should be a standard part of clinical care. At the initial patient visit, 90% ask patients about tobacco use, 79% ask patients whether they will quit, 81% advise patients to stop tobacco use, but only 40% discuss medication options, 39% actively provide cessation assistance, and fewer yet address tobacco at follow-up. Dominant barriers to physician cessation effort are pessimism regarding their ability to help patients stop using tobacco (58%) and concerns about patient resistance to treatment (67%). Only 33% report themselves to be adequately trained to provide cessation interventions. CONCLUSION: Physicians who care for lung cancerpatients recognize the importance of tobacco cessation as a necessary part of clinical care, but many still do not provide assistance to their patients as a routine part of cancer care. Increasing tobacco cessation activities will require increased assessment and cessation at diagnosis and during follow-up, increased clinician education, and improved tobacco cessation methods.
Authors: Csaba Gajdos; Mary T Hawn; Elizabeth J Campagna; William G Henderson; Jasvinder A Singh; Thomas Houston Journal: Ann Surg Oncol Date: 2011-11-08 Impact factor: 5.344
Authors: Adam O Goldstein; Carol E Ripley-Moffitt; Donald E Pathman; Katharine M Patsakham Journal: Nicotine Tob Res Date: 2012-04-11 Impact factor: 4.244
Authors: Mary E Cooley; Qian Wang; Bruce E Johnson; Paul Catalano; Robert I Haddad; Raphael Bueno; Karen M Emmons Journal: Lung Cancer Date: 2011-11-16 Impact factor: 5.705
Authors: Sang Min Park; Min Kyung Lim; Kyu Won Jung; Soon Ae Shin; Keun-Young Yoo; Young Ho Yun; Bong Yul Huh Journal: J Clin Oncol Date: 2007-10-20 Impact factor: 44.544
Authors: Katherine R Sterba; Elizabeth Garrett-Mayer; Matthew J Carpenter; Janet A Tooze; Jeanne L Hatcher; Christopher Sullivan; Lee Anne Tetrick; Graham W Warren; Terrence A Day; Anthony J Alberg; Kathryn E Weaver Journal: Laryngoscope Date: 2016-07-09 Impact factor: 3.325
Authors: Allison J Carroll; Anna K Veluz-Wilkins; Sonja Blazekovic; Ravi Kalhan; Frank T Leone; E Paul Wileyto; Robert A Schnoll; Brian Hitsman Journal: Psychooncology Date: 2017-08-04 Impact factor: 3.894
Authors: Benjamin A Toll; Alana M Rojewski; Lindsay R Duncan; Amy E Latimer-Cheung; Lisa M Fucito; Julie L Boyer; Stephanie S O'Malley; Peter Salovey; Roy S Herbst Journal: Clin Cancer Res Date: 2014-01-16 Impact factor: 12.531
Authors: Eleni M Rettig; Carole Fakhry; Russell K Hales; Flora Kisuule; Harry Quon; Ana P Kiess; Linda X Yin; Yuehan Zhang; Amanda L Blackford; M Bradley Drummond; Christine G Gourin; Wayne M Koch; David W Eisele; Gypsyamber D'Souza Journal: Head Neck Date: 2018-03-15 Impact factor: 3.147
Authors: Jessica L Burris; Jamie L Studts; Antonio P DeRosa; Jamie S Ostroff Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-08-17 Impact factor: 4.254
Authors: Alexis J Platek; Vijayvel Jayaprakash; Mihai Merzianu; Mary E Platek; David M Cohan; Wesley L Hicks; Sathiya P Marimuthu; Timothy B Winslow; Vishal Gupta; Hassan Arshad; Moni A Kuriakose; Shiva Dibaj; James R Marshall; Mary E Reid; Graham W Warren; Anurag K Singh Journal: Laryngoscope Date: 2016-06-27 Impact factor: 3.325